Feel Therapeutics
AI-enabled Digital Precision Medicine to reinvent the way we diagnose, manage, and care for Mental Health
- Founded
- 2015
- Website
- myfeel.co
- Total Funding
- $18.2M
- Last Round
- $7.9M Venture RoundApr 2025
About
Feel Therapeutics is a Digital Precision Medicine company that brings continuous and passive physiological monitoring into the field of mental healthcare. Its AI-powered platform collects data 24/7 from wearables, digital health apps, and mobile devices to generate objective physiological and digital biomarkers for mental health conditions including depression, anxiety, ADHD, stress, and insomnia. The company offers three core solutions: Feel 360 for clinical trials and real-world studies, Feel RxPal for improving patient adherence and engagement, and Feel DTx for precision digital therapeutics. Partners include Johnson & Johnson, Janssen, Bayer, Biogen, and SCOR, with published clinical outcomes in Nature Digital Medicine.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account